by Ray Holder » Wed Jul 08, 2009 2:12 pm
I have to admit that most of sylviak's links go over my head, but the apparently good link below shows that although all known factors were taken into account, others, not known at the time, could well have had an effect on the observed outcomes. I refer to the statement that some candidates were taking beta blockers, now known to reduce the body's Q10 supply, so adding an unknown into the Q10 levels of those using them, and others were using calcium channel inhibitors, now known to interfere with the disposal of statins, thus enhancing their length of stay in the body
*http://www.jlr.org/cgi/content/full/39/7/1430
These factors could well have influenced the results, as they were only a passing note in the paper, and any differences in results ignored, but they would have made the apparent Q10 performance worse.
I do not know the circumstances of all these trials, but I am wary of peer reviews of cholesterol associated studies, which often are heavily funded by industry, and the reviewing peers may well be under the same financial constraints as the authors.
Ray